- Full Year 2023 Smith & Nephew PLC Earnings Call TranscriptFeb 27, 2024$14.19Earnings
- Smith & Nephew PLC Meet the Management Event TranscriptNov 29, 2023
- Q3 2023 Smith & Nephew PLC Trading Statement Call TranscriptNov 02, 2023
- Half Year 2023 Smith & Nephew PLC Earnings Call TranscriptAug 03, 2023$13.91 (-6.46%)Earnings
- Q1 2023 Smith & Nephew PLC Trading Statement Call TranscriptApr 26, 2023
- Full Year 2022 Smith & Nephew PLC Earnings Call TranscriptFeb 21, 2023$14.64 (+5.31%)Earnings
- Q3 2022 Smith & Nephew PLC Trading Statement Call TranscriptNov 03, 2022
- Half Year 2022 Smith & Nephew PLC Earnings Call TranscriptJul 28, 2022$13.4Earnings
- Q1 2022 Smith & Nephew PLC Trading Statement Call TranscriptApr 28, 2022
- Full Year 2021 Smith & Nephew PLC Earnings Call TranscriptFeb 22, 2022$16.61Earnings
- Smith & Nephew PLC Meet the Management Event TranscriptDec 16, 2021
- Q3 2021 Smith & Nephew PLC Trading Statement Call TranscriptNov 04, 2021
- Half Year 2021 Smith & Nephew PLC Earnings Call TranscriptJul 29, 2021$20.62 (-7.59%)Earnings
- Q1 2021 Smith & Nephew PLC Trading Statement Call TranscriptApr 29, 2021
- Full Year 2020 Smith & Nephew PLC Earnings Call TranscriptFeb 18, 2021$21.47Earnings
- Q3 2020 Smith & Nephew PLC Trading Statement Call TranscriptOct 29, 2020
- Smith & Nephew PLC Innovation in Focus - Virtual Investor Event TranscriptSep 08, 2020
- Half Year 2020 Smith & Nephew PLC Earnings and Q2 2020 Trading Statement Call TranscriptJul 29, 2020
- Q1 2020 Smith & Nephew PLC Trading Statement Call TranscriptMay 06, 2020
- Full Year 2019 Smith & Nephew PLC Earnings Call TranscriptFeb 20, 2020$25.5 (+4.94%)Earnings
- Q3 2019 Smith & Nephew PLC Trading Statement Call TranscriptOct 31, 2019
- Q2 2019 Smith & Nephew PLC Earnings Call TranscriptJul 31, 2019$22.64 (+0.62%)Earnings
- Q1 2019 Smith & Nephew PLC Trading Statement Call TranscriptMay 02, 2019
- Smith & Nephew PLC to Acquire Osiris Therapeutics Inc Call TranscriptMar 12, 2019
Q3 2019 Smith & Nephew PLC Trading Statement Call Transcript
(technical difficulty)
Certain statements in this presentation are forward-looking statements. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these -- from those included in these statements due to a variety of factors. More information about these factors is contained in the company's filings with the Securities and Exchange Commission.
I would like to hand the call now to our first speaker, Mr. Graham Baker, the CFO. Thank you. Please go ahead.
Thanks, operator, and good morning, everyone. Welcome to Smith & Nephew's Third Quarter 2019 Trading Update. I'm here with Skip Kiil, President of our Global Orthopaedics franchise; and Phil Cowdy, who you all know well.
First, I'll take you through the detail of the third quarter, with 4% underlying sales growth and 3.9% year-to-date, as well as our progress on integrating the recent
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)